Sodium Bicarbonate Injection
Product Images NDC 51662-1383

11 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sodium Bicarbonate (NDC 51662-1383). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
A data table presenting sodium bicarbonate injection product details including stock number, NDC number, dosage form as prefilled syringe, concentration at 8.4%, and strength of 84 mg/mL. It also lists sodium and bicarbonate content per mL, container size as 50 mL, and osmolarity of 2 mOsm/mL.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
An instructional diagram showing three steps for preparing an intravenous injection of sodium bicarbonate. Step 1 shows removing protective caps from the vial and injector. Step 2 illustrates threading the vial into the injector until the stopper is pierced by the metal cannula, with a warning not to push the vial into the injector to avoid misalignment. Step 3 demonstrates removing the cover and expelling air before injection.*
FDA Label Image

5662-1383-1 Carton Label (51662 1383 1 Syr Carton Label)

5662-1383-1 Carton Label (51662 1383 1 Syr Carton Label)
Packaging label for Sodium Bicarbonate Injection USP, 8.4%, in a 50 mEq/50 mL (1 mEq/mL) Luer-Jet Luer-Lock prefilled syringe. The label is mustard yellow with black text and includes usage instructions, storage information, and warnings. It is labeled for intravenous use, single-dose, and distributed by International Medication Systems, Limited, and HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

51662-1383-1 Syr Vial Label (51662 1383 1 Syr Vial Label)

51662-1383-1 Syr Vial Label (51662 1383 1 Syr Vial Label)
Label for Sodium Bicarbonate USP 8.4% injection, 84 mg/mL strength, in a 50 mL single-dose vial. The label indicates intravenous use, sterile and non-pyrogenic formulation, with no preservatives added. It includes a dosing scale in mEq per mL and branding by IMS Limited, So. El Monte, CA, USA, under HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Serialized Label (51662 1383 1 Serialized Carton Labeling)

Serialized Label (51662 1383 1 Serialized Carton Labeling)
Sodium Bicarbonate Injection USP 8.4% prefilled syringe packaging box. The label indicates a 50 mEq/50 mL strength in a single 50 mL unit dose. The box is yellow with white and black text, includes a Luer-Lock prefilled syringe illustration, and specifies intravenous use only. The product is labeled as Rx only and manufactured by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Rfid Label (51662 1383 1 Rfid Label)

Rfid Label (51662 1383 1 Rfid Label)
Close-up of a white label containing GS1 barcode data and text referencing the distributor HF Acquisitions Co., LLC, Mukilteo, WA. The label includes numeric and alphanumeric identifiers, a QR-style barcode, and the instruction to see the manufacturer's insert. The product is not explicitly named on this label portion.*
FDA Label Image

Box Labeling (Individual Box)

Box Labeling (Individual Box)
Sodium Bicarbonate Injection USP, 8.4%, 50 mEq/50 mL (1 mEq/mL) in a single-dose prefilled syringe for intravenous use. The carton features the product name, strength, dosage form, route, and packaging details, including Luer-Jet Luer-Lock prefilled syringe design. Labeler is HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Pouch Labeling (51662 1383 2 Pouch Label)

Pouch Labeling (51662 1383 2 Pouch Label)
Label for Sodium Bicarbonate Injection USP, 8.4% (84 mg/mL) in a 50 mL Luer-Jet syringe. The label includes lot number, expiration date, and handling instructions. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The NDC listed is 51662-1383-2. The label specifies use for intravenous injection only and notes no preservative added.*
FDA Label Image

Syringe Label (Syringe Label)

Syringe Label (Syringe Label)
Label for Sodium Bicarbonate USP Injection, 8.4%, containing 84 mg/mL sodium bicarbonate. The label indicates a 50 mL single dose vial for intravenous use, with a concentration of 50 mEq/50 mL. It includes instructions such as sterile, non-pyrogenic, no preservative added, and to discard unused portions. The product is labeled by IIMS, Limited, located in El Monte, California, and also features a black and yellow color scheme with measurement markings.*
FDA Label Image

Case Labeling (51662 1383 3 Case Label)

Case Labeling (51662 1383 3 Case Label)
Label for Sodium Bicarbonate Injection USP 8.4%, 50 mEq/50 mL (1 mEq/mL) in a 50 mL Luer-Jet syringe. This is a case label for a set of 10 syringes, manufactured by HF Acquisition Co LLC. The label includes lot and expiration details, handling instructions, and storage conditions. The product is for intravenous use only.*
FDA Label Image

Rfid Label (51662 1383 3 Rfid)

Rfid Label (51662 1383 3 Rfid)
A close-up image of a label on a pharmaceutical product showing barcodes, text codes including (01), (17), (21), and (10) identifiers, and instructions to see the manufacturer's insert. The label states distribution by HF Acquisitions Co., LLC in Mukilteo, WA. The product is Sodium Bicarbonate injection, 84 mg/mL, for intravenous use, labeled by HF Acquisition Co LLC DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.